3
Clinical Trials associated with BPR-101一项评估BPR-101胶囊在细菌性阴道病(BV)患者中有效性及安全性的II期临床试验
[Translation] A Phase II clinical trial evaluating the efficacy and safety of BPR-101 capsules in patients with bacterial vaginosis (BV)
主要目的
评估BPR-101胶囊在BV患者中的有效性。
次要目的
评估BPR-101胶囊在BV患者中的安全性。
[Translation] Primary objective
To evaluate the efficacy of BPR-101 capsules in BV patients.
Secondary objective
To evaluate the safety of BPR-101 capsules in BV patients.
一项评估BPR-101胶囊多次给药在细菌性阴道病(BV)患者中的安全性、耐受性及初步有效性的Ib期临床试验
[Translation] A Phase Ib clinical trial evaluating the safety, tolerability and preliminary efficacy of multiple doses of BPR-101 capsules in patients with bacterial vaginosis (BV)
主要目的
评估BPR-101胶囊多次给药在BV患者中的安全性和耐受性。
次要目的
评估BPR-101胶囊多次给药在BV患者中的有效性。
[Translation] Primary objective
To evaluate the safety and tolerability of multiple administrations of BPR-101 capsules in BV patients.
Secondary objective
To evaluate the efficacy of multiple administrations of BPR-101 capsules in BV patients.
BPR-101胶囊在健康受试者中的安全性和耐受性临床试验
[Translation] Clinical trial on the safety and tolerability of BPR-101 capsules in healthy subjects
主要目的:评估BPR-101胶囊单剂量递增给药后健康受试者的安全性和耐受性;确定最大耐受剂量(MTD)(如有)、剂量限制性毒性(DLT)(如有),Ⅱ期临床推荐剂量(RP2D)和给药方案。
次要目的:探索BPR-101胶囊对阴道菌群的影响。
[Translation] Primary objective: To evaluate the safety and tolerability of BPR-101 capsules in healthy subjects after single-dose ascending administration; to determine the maximum tolerated dose (MTD) (if any), dose-limiting toxicity (DLT) (if any), recommended dose for Phase II clinical trials (RP2D) and dosing regimen.
Secondary objective: To explore the effect of BPR-101 capsules on vaginal flora.
100 Clinical Results associated with BPR-101
100 Translational Medicine associated with BPR-101
100 Patents (Medical) associated with BPR-101
100 Deals associated with BPR-101